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Abstract Ageing is accompanied with a decline in
respiratory function. It is hypothesised that this may
be attenuated by high physical activity levels. We
performed spirometry in master athletes (71 women;
84 men; 35–86 years) and sedentary people (39 wom-
en; 45 men; 24–82 years), and calculated the predicted
lung age (PLA). The negative associations of age with
forced expiratory volume in 1 s (FEV1; 34 mL·year
−1)
and other ventilatory parameters were similar in con-
trols and master athletes. FEV1pred was 9 % higher
(P<0.005) and PLA 15 % lower (P00.013) in athletes
than controls. There were no significant differences
between endurance and power athletes and sedentary
people in maximal inspiratory and expiratory pressure.
Neither age-graded performance nor weekly training
hours were significantly related to lung age. Life-long
exercise does not appear to attenuate the age-related
decrease in ventilatory function. The better respiratory
function in master athletes than age-matched sedentary
people might be due to self-selection and attrition bias.
Keywords FEV1 . Lung age .Mouth pressure .
Physical activity . Peak expiratory flow . Physical
exercise
Introduction
During ageing, there is a progressive decline in respira-
tory function, due to factors such as a loss of respiratory
muscle strength (Hautmann et al. 2000; Dempsey et al.
1990), increased stiffness of the chest wall, reduced elas-
tic recoil of the lung and diffusion capacity, which ulti-
mately may result in hypoxaemia even at rest (Hankinson
et al. 1999; Klocke 1977). Although high physical activ-
ity levels may attenuate the age-related decline in respi-
ratory function (Pelkonen et al. 2003; Freitas et al. 2010;
Amara et al. 2001; Nystad et al. 2006), it is particularly in
the elite endurance athlete that exercise performance is
limited by hypoxaemia due to constraints of the respira-
tory system (Dempsey et al. 1990; Dempsey et al. 2008).
One explanation for this apparent contradiction could be
that the plasticity of the respiratory system is limited
(Dempsey et al. 1990) due to, e.g. the size of the thorax
AGE (2013) 35:1007–1015
DOI 10.1007/s11357-012-9409-7
H. Degens (*) : T. M. Maden-Wilkinson :A. Ireland :
J. S. McPhee : J. Rittweger
Institute for Biomedical Research into Human Movement
and Health, Manchester Metropolitan University,
John Dalton Building; Chester Street,
Manchester M1 5GD, UK
e-mail: h.degens@mmu.ac.uk
H. Degens : J. Rittweger
Division Space Physiology, Institute of Aerospace
Medicine, German Aerospace Center,
Cologne, Germany
M. T. Korhonen :H. Suominen :A. Heinonen
Department of Health Sciences, University of Jyväskylä,
Jyväskylä, Finland
Z. Radak
Research Institute of Sport Science,
Semmelweis University,
Budapest, Hungary
and inability to increase blood volume in the lung despite
increases in flow during training sessions. Nevertheless,
we hypothesise that the exceptional demands placed on
the respiratory system by themaster athlete may attenuate
the normally occurring age-related deterioration of the
respiratory system.
Over the last decade we have done a series of
studies in master athletes (Michaelis et al. 2008;
Korhonen et al. 2006; Rittweger et al. 2009; Rittweger
et al. 2004; Wilks et al. 2009; Ireland et al. 2011), i.e.
people who train for and compete in their sports be-
yond a certain age, e.g. the age of 35 in track and field
athletics (Reaburn and Dascombe 2008). Their out-
standing performances are evidenced by the world
record data (Rittweger et al. 2009). Since master ath-
letes (a) train as vigorously as they possibly can, and
(b) withdraw from competitions when they become
sick or otherwise impaired, they constitute a unique
population to study age-related changes without (or
with very little) contribution of two usual confounders
of old age, namely sedentarism and co-morbidity
(Rittweger et al. 2004). The aim of the present study
was therefore to compare in a cross-sectional study
respiratory function in track and field master athletes
and sedentary control people. Since the oxygen de-
mand, and hence ventilation, is elevated over pro-
longed periods in exercising endurance athletes we
hypothesised that the endurance runners would have
better ventilatory function than age-matched power
master athletes and a more sedentary population.
While others have previously reported ventilatory
function in master athletes, they did not include a
control group, or only studied endurance athletes
(McClaran et al. 1995; Pollock et al. 1974).
Materials and methods
Participants
We recruited 71 female and 84 male athletes at the
World Master Athletics Championships in 2009
(Lahti, Finland) and the European Veterans Athletics
Championships in 2010 (Nyíregyháza, Hungary).
Master athletes are typically defined as ‘athletes older
than 35 years of age and systematically train for, and
compete in, organized forms of sport specifically
designed for older adults’ (Reaburn and Dascombe
2008). Three athletes had an Asian background, two
an African and the others were white Caucasians.
Control participants (men n045; women n039) were
recruited and measured at the Manchester Metropoli-
tan University. Current smokers were excluded from
the control group. One female endurance and one male
power athlete reported they smoked, but less than a
cigarette per day. Some of the athletes and control
participants have been smoking in the past but their
ventilatory function was in the normal range for the
respective groups and their data were included in the
analysis. Data were excluded if the forced expiratory
volume in 1 s (FEV1) was below the 70 % predicted
value and/or the FEV1/vital capacity (FEV1/FVC) was
below 70 % (one case; www.goldcopd.com). The
study was approved by the ethical committees of the
Manchester Metropolitan University, University of
Jyväskylä (Finland) and the Semmelweis Institute
(Budapest, Hungary). All participants had given writ-
ten informed consent before inclusion.
Middle- and long-distance runners (800 m–mara-
thon), race-walkers andmulti-event athletes (pentathlon,
decathlon) were classified as endurance athletes, while
sprinters and hurdlers (100–400 m), jumpers (long and
triple jump, pole vault) and throwers (hammer, javelin,
discuss, shot-put) as power athletes. The following
groups were formed: Female Endurance (FE), Female
Power (FP), Male Endurance (ME), Male Power (MP)
athletes, and Female (FC) and Male (MC) control.
In master athletes, the self-rated best discipline,
number of training sessions per week and the hours
per session were assessed by interview. The age-
graded performance (AGP) for the main event of the
master athletes was calculated using the WMA Age-
grading Calculator:
h t tp : / /www.howardgrubb.co .uk/a th le t ics /
wmalookup06.html.
Spirometry
All experiments were performed using the same Micro
Medical Spiro USB Spirometer and analysed with
Spida 5 software (Cardinal Health, UK). The calibra-
tion of the spirometer was checked on a daily basis
according to the ATS/ERS criteria (Miller et al. 2005).
All experiments were performed in a seated position.
Participants wore a noseclip and performed a maximal
inspiration immediately followed by a forced maximal
expiration. This procedure was repeated until the cri-
teria set out by the ATS and ERS were met, i.e. a
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plateau in the expiration, expiration >6 s, no coughs
and between-test variation for Forced Vital Capacity
(FVC in liters) and FEV1 <0.15 L (Miller et al. 2005).
Whenever participants did not fulfil the criteria,
manoeuvres were repeated and checked for a quick
start, early peak flow and sufficient expiration (Miller
et al. 2005). The presented parameters are: FEV1 (in
liters), FVC, Peak Expiratory Flow (PEF, in liters per
second) and FEV1/FVC (in percent). The predicted
values for FEV1 (FEV1pred) and PEF (PEFpred) were
calculated according to equations that include age and
height as provided by The Third National Health and
Nutrition Examination Survey taking into account eth-
nic background (Hankinson et al. 1999). That
population-based study examined respiratory function
in a USA population of 7,429 healthy live-long non-
smokers between 8 and 80 years of age; people suf-
fering from wheezing, coughs, asthma, chronic ob-
structive pulmonary disease and lung cancer were
excluded. Using the ‘normal values’ reported by Han-
kinson et al. (1999) in 988 healthy non-smokers be-
tween 20 and 84 years of age the following equations
to calculate predicted lung age (PLA) using the ma-
noeuvre with the highest FVC+FEV1 were derived by
(Morris and Temple 1985):
Men : PLA yð Þ ¼ 1:130  H cmð Þ  31:25  FEV1 Lð Þ  39:375
Women : PLA yð Þ ¼ 1:402  HðcmÞ  40:00  FEV1 Lð Þ  77:280
Where PLA is the predicted lung age in years and H
is height in cm. Since FEV1 increases during matura-
tion and reaches a peak between 20–25 years of age
(Hankinson et al. 1999), the minimum lung age is set
at 24 by the Spida software, while the maximum lung
age is set at 80 years.
In a small number of athletes (MP: 5; ME: 4; FP: 4;
FE 3) the diffusion capacity for carbon monoxide of
the lungs (DL,CO) could also be determined at the Lahti
City Hospital. Thereto, the participant was asked to
exhale to residual volume and then quickly inhale till
total lung capacity form the gas source with 0.3 % CO.
After a 10-s breath-hold the participant was asked to
exhale as fast as possible. Slots for DL,CO testing were
only available in the evening hours and no such pos-
sibility existed in Nyíregyháza. These data are pre-
sented as %DL,COpred (Macintyre et al. 2005).
In the master athletes from Lahti and seven control
participants, the maximal inspiratory (MIP) and expira-
tory (MEP) pressure were determined using a portable
mouth pressure device (MicroRPM, Cardinal
Healthcare, UK) as described previously (Hautmann et
al. 2000). Thereto, participants were asked to inspire or
expire as forcefully as possible after total expiration or
inspiration respectively into the portableMicroRPM. To
determine the maximal sniff nasal inspiratory pressure
(SNIP) participants placed a probe in one of their nos-
trils while the other nostril was closed and the partici-
pant inspired as fast and as forceful as possible via the
nose. For all manoeuvres, attempts were repeated, with a
30s interval between each attempt to prevent the devel-
opment of respiratory muscle fatigue, until a maximum
value was reached. Data are reported in kilopascals.
Statistics
Statistical analyses were carried out using SPSS 16.0.
Differences between groups were compared with a two-
wayANOVAwith sex (men vs. women) and sport (three
levels: control, power and endurance athletes) as factors
and age as co-variate. A Kolmogorov–Smirnov test
showed that all respiratory parameters had a normal
distribution. If a significant sport effect was found a
Bonferroni corrected post-hoc test was performed to
detect the differences. Relationships between parame-
ters are given as Pearson correlation coefficients. Differ-
ences and correlations were considered significant atP<
0.05. Values are reported as means±SD.
Results
Participant characteristics
Height was negatively (R200.055; P<0.001) and BMI
was positively (R200.039; P00.002) related to age
(data not shown). Body mass index (BMI) was lowest
in endurance athletes (P<0.001; Table 1). The weekly
training hours were negatively related to age, indicat-
ing a decrement of 0.76 hours training per week per
decade (Fig. 1; R200.063; P<0.015; excluding an
outlier who reported 50 h·wk−1 of training). The week-
ly training hours showed no significant correlation
with the AGP of the athletes.
Spirometry
The average ventilatory parameters predicted for age
in the control and athletic groups are shown in Table 2.
In Fig. 2 it can be seen that the FEV1 was higher in
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men than women (P<0.001) and that it was negatively
related to age (men R200.47; women R200.61); this
decrease amounted to about 34 mL·year−1 in all
groups, irrespective of being an athlete or not. The
FEV1 of both endurance and power athletes was,
however, higher than that of control participants (P<
0.05). Also FEV1pred was 9 % points higher in the
athletes than in control participants (P<0.005), with
no difference between power and endurance athletes
(P00.116, Table 2).
FVC was negatively associated with age in all
groups (slope of linear regression, 36 mL·year−1;
R200.24; P<0.001; Fig. 3). Men had a larger FVC
than women (P<0.001) and the FVC of control par-
ticipants was smaller than that of athletes (Fig. 3). The
FEV1/FVC was approximately 5 % higher in control
participants than athletes (P<0.001; Table 2). PEF was
higher in men than women and negatively associated
with age (P<0.001; men R200.23; women R200.38;
Fig. 4). PEF and PEFpred were higher in the athletes
than controls (P<0.001; Fig. 4 and Table 2). Athletes
had on average a 15 % lower PLA than age-matched
controls (P<0.05; Table 2), corresponding with the
higher FEV1 in athletes. Excluding people with a
PLA of 24 and 80 years gave essentially the same
result, though the difference between power athletes
and controls disappeared (P00.232).
Figure 5 suggests that master athletes, indepen-
dent of their specialty, might have a better
Table 1 Participant characteristics
FE n037 FP n034 FC n039 ME n034 MP n048 MC n045
Age (years) 56±11 (39–84) 56±12 (36–81) 63±18 (24–82) 62±13 (35–86) 57±15 (35–85) 59±21 (24–81)
Body mass(kg) 54.6±6.3a
(40.0–68.0)
65.4±15.8a,c
(58.0–115.0)
66.7±13.9a,c
(33.0–109.5)
68.0±9.0
(54.0–94.0)
76.5±11.6c
(55.0–114.0)
76.5±15.9c
(46.0–118.0)
Height (m) 1.63±0.07b
(1.48–1.76)
1.65±0.08a
(1.47–1.83)
1.62±0.07a,b
(1.45–1.82)
1.73±0.07a,b
(1.61–2.00)
1.77±0.08
(1.60–1.94)
1.73±0.08b
(1.56–1.90)
BMI (kg·m−2) 20.4±1.5
(17.1–24.1)
23.9±4.6c
(19.1–37.6)
25.5±5.1c
(15.1–40.3)
22.6±2.4
(18.1–29.1)
24.2±2.5c
(19.5–30.5)
25.3±4.3c
(17.7–38.5)
AGP (%) 81±10 (59–98) 76±12 (49–93) NA 79±12 (32–94) 83±11 (53–96) NA
Training (h) 8.7±5.0 (3.0–20.0) 7.9±5.2 (0.5–20) NA 7.9±3.7 (3.5–20.0)d 7.7±3.0 (1.0–15.0) NA
Mean±SD (range)
FE female endurance; FP female power; FC female control; ME male endurance; MP male power; MC male control; BMI body mass
index; AGP age-graded performance; NA not applicable
a Different from men at P<0.001
b Different from power athletes P<0.02
c Different from Endurance athletes
d Excluding a person who claimed to train 50 hours per week
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Fig. 1 a Training hours per week and b relationship between
age-graded performance (AGP) and training hours of master
athletes at different ages. FE Female endurance; FP female
power; ME male endurance; MP male power. Linear regression
line: training h·wk−10−0.0759×age (years)+12.523; R20
0.0625; P00.014
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diffusion capacity than expected. Although it may
appear from the figure that this advantage could
diminish after the age of 50, this remains specula-
tive because of the small sample size.
Inspiratory and expiratory pressures
The MEP (Fig. 6a), MIP (Fig. 6b) and SNIP (Fig. 6c)
were all higher in men than women and negatively
related with age (0.048<R2<0.17; P<0.05). There
was no significant difference in any of these parame-
ters between endurance and power athletes or control
participants. The FEV1 (Fig. 7a; R
200.18; P<0.001)
and PEF (Fig. 7b; R200.22; P<0.001) correlated with
MEP.
Respiratory function and training status
FEV1pred (R
200.025; P<0.02) and PEFpred (R
20
0.026; P<0.02) were negatively associated with
BMI. PLA did not depict any relationship with AGP
(R200.032; P00.076) or training hours per week (R20
0.026; P00.176).
Discussion
This cross-sectional study has compared ventilatory
function of Master athletes with a more sedentary refer-
ence population and with established cohort data from
the literature (Hankinson et al. 1999). The main findings
were that Master athletes have greater FVC, FEV1 and
FEV1pred values, but lower FEV1/FVC and predicted
lung age than the more sedentary population. No group
differences were found in ventilatory pressures (MEP,
MIP or SNIP). Overall, with the exception of FEV1/
Table 2 Ventilatory characteristics in athletes and controls
FE n035 FP n028 FC n038 ME n030 MP n042 MC n045
FEV1PRED (%) 105.4±13.4
a 101.1±12.6a 94.1±11.4 107.6±9.8a 102.6±12.5a 96.5±14.4
FEV1/FVC 73.3±7.3
a 76.0 ±5.5a 80.8±6.1 74.6±8.5a 74.5±7.8a 78.8±6.1
PEFPRED 104.9±20.4
a 104.8±13.7a 88.2±20.6 106.3±16.2a 107.8±17.3a 96.6±20.1
PLA/age 0.87±0.24b 0.93±0.29b 1.09±0.27 0.86±0.18b 0.94±0.25b 1.03±0.27
Mean±SD; for further description of statistics, see text
FE female endurance; FP female power; FC female control; ME male endurance; MP male power; MC male control; BMI body mass
index; FEV1pred predicted forced expiratory volume in 1 s; FVC/FEV1 forced vital capacity divided by FEV1; PEFpred predicted peak
expiratory flow; PLA predicted lung age
a Different from control participants at P<0.005
b Different from control participants at P<0.05
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Fig. 2 Individual data for forced expiratory volume in 1 s
(FEV1); solid line men: FEV10−0.034*age (yrs)+5.54; R20
0.47; P<0.001; broken line women: FEV10−0.033×age
(years)+4.56; R200.61; P<0.001. FE Female endurance; FP
female power; FC female control; ME male endurance; MP
male power; MC male control participants. For further descrip-
tion of statistics, see text
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Fig. 3 Forced vital capacity (FVC) in FE female endurance; FP
female power; FC female control; ME male endurance; MP
male power; MC male control participants
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FVC, it is concluded that ventilation, i.e. the convective
gas transport in the respiratory system, is better in Mas-
ter athletes than non-athletes.
Most of the athletes adhered to a high volume of
training, similar to those reported before (Ireland et al.
2011; Korhonen et al. 2006). This and the similar age-
graded performance to that seen in previous work
(Wilks et al. 2009) indicates that our sample of Master
athletes were a ‘typical’ selection, even if no systematic
study exists regarding exercise habits in these people.
However, because of self-selection (after all it is the
Master athletes themselves who decide to participate in
their sports) it cannot be determined here (and in fact
also not easily in other studies) whether the observed
benefits are a cause or an effect of the athletic engage-
ment and intense training. What will be discussed in the
following, however, is whether long-term engagement
in sports, such as master athletics, could mitigate the
well-established decline in respiration, keeping in mind
the limitations of a cross-sectional design.
Is the better ventilatory function in master athletes
due to higher exercise levels?
Not only cross-sectional (Amara et al. 2001; Nystad et
al. 2006) but also longitudinal (Pelkonen et al. 2003)
studies have reported that high physical activity levels
attenuate the age-related decline in respiratory func-
tion. Our data appear to support the benefit of regular
exercise for ventilatory function as also the ventilatory
function of master athletes was better than that of age-
matched non-athletes, to such an extent that the lungs
of both power and endurance master athletes were on
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Fig. 4 Peak expiratory flow (PEF) in FE female endurance; FP
female power; FC female control; ME male endurance; MP
male power; MC male control participants. For description of
statistics, see text
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Fig. 6 aMaximal expiratory (MEP), b inspiratory (MIP) mouth
pressures and c sniff nasal inspiratory (SNIP) pressure in FE
female endurance; FP female power; FC female control; ME
male endurance; MP male power; MC male control
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average 15 % ‘younger’ than non-master athletes. Part
of a potential beneficial effect of high physical activity
levels on ventilatory function might be attributable to
a higher respiratory muscle strength (Freitas et al.
2010; Hautmann et al. 2000), but our preliminary data
showed no significant differences in respiratory mus-
cle strength between athletes and controls. In fact, the
main benefit of respiratory muscle training for im-
proved endurance exercise performance is not so
much derived from an increased strength as from an
increased endurance of the respiratory muscles (Spen-
gler and Boutellier 2000), which has not been tested
here, but must be suspected to contribute to their
running performance. In any case, the similar respira-
tory muscle strength across athletes and their seden-
tary counterparts suggests that factors independent of
the respiratory muscles, such as lung recoil and chest
compliance, contribute to the better ventilatory func-
tion in the athletes. These factors are essentially non-
trainable, and if so the inherently better ventilatory
function may induce people to engage in sports. In
other words, the better ventilatory function of the
master athletes might be a reflection of self-selection
bias to participate in sports.
Respiratory function: a determinant of aerobic
performance at old age?
Endurance athletes have a higher and prolonged de-
mand for gas exchange, and thus ventilation during
exercise than power athletes and non-athletes. This is
reflected by the observation that endurance athletes
might develop hypoxaemia (Dempsey et al. 2008;
Prefaut et al. 1994). Therefore, we hypothesised that
ventilatory function would be better maintained during
ageing in endurance athletes. In line with our expec-
tation athletes indeed had better respiratory function
than age-matched controls, but in contrast to our ex-
pectation there was no difference between endurance
and power athletes. As in the control population, also
in the master endurance athletes the older individuals
had a lower ventilatory function. This might explain
why master endurance athletes might develop hypo-
xaemia even earlier and with larger magnitudes during
exercise than young endurance athletes (McClaran et
al. 1995; Prefaut et al. 1994). It has been suggested
that hypoxaemia may be caused by initial hypoventi-
lation followed by increased interstitial pulmonary
oedema (Prefaut et al. 1994). Overall, the data pre-
sented here and the rapid decline in ventilatory func-
tion without a decline in maximal heart rate over a 6-
year period (McClaran et al. 1995) suggest that the
age-related deterioration of respiratory function out-
runs the function of other determinants of aerobic
capacity. It thus might be that limits in ventilatory
function become more important in determining en-
durance performance at old age.
Possible contributors to the age-related decline
in ventilation
Although one might still argue that the better ventilatory
function in master athletes than the control group is
explicable by their higher levels of physical activity,
we would like to draw the attention to the similar slopes
of the regression lines of FEV1 vs. age in our control
population and master athletes (−34 mL·year−1). It thus
seems as though athletes may start ‘higher’ when they
are young, but would then be ‘losing’ ventilatory func-
tion at the same rate as the average population. This
suggests that the effects of age are inert to exercise,
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sure (MEP) with a forced expiratory volume in 1 s (FEV1) and b
peak expiratory flow (PEF) in FE: Female endurance; FP fe-
male power; FC female control; ME male endurance; MP male
power; MC male control
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neither mitigating the age-related decline nor enhancing
ventilatory function. In fact, a longitudinal study has
even reported that FEV1 over 5 years increased in those
with low, but decreased in those with high cardiorespi-
ratory fitness at the first visit (Cheng et al. 2003). More-
over, a 12-week endurance training programme did not
induce any changes in ventilatory function except for an
increase in PEF in men but not women (Hulke and
Phatak 2011). In another study former athletes had a
higher FEV1 and FVC than currently active 60–67-year-
old athletes (Saltin and Grimby 1968) and young endur-
ance athletes had similar ventilatory function as young
sedentary people (Hagberg et al. 1988). These observa-
tions and the absence of significant correlations between
training hours per week or age-graded performance with
ventilatory function in our master athletes further sup-
ports the idea that regular physical activity has limited, if
any, impact on ventilatory function, e.g. due to structural
limitations of the respiratory system (Dempsey et al.
1990; Harms 2006), or that it may even be detrimental.
If exercise is indeed detrimental to ventilatory func-
tion the downward slope of FEV1 over age should
have been steeper in athletes, which was not observed.
However, it is almost certain that our cross-sectional
data are affected by attrition bias in the master athletes,
as those athletes with particularly poor ventilatory
function are likely to end their sporting career, thus
generating a ‘fitter’ group average by their absence.
This interpretation is indeed supported by a longitudi-
nal study on endurance master athletes where it was
found that the decline in respiratory function, such as
PEF and FEV1, over a 6-year period was in fact larger
than expected from cross-sectional studies (McClaran
et al. 1995).
Study limitations
One limitation is that the master athletes came from all
over the globe while control participants were primarily
from Manchester, UK. Nevertheless, the age-related
differences in ventilatory function followed similar pat-
terns in each population and were similar to those ob-
served in a 5-year follow-up study (Rossi et al. 2011).
This suggests that the different origin of the study pop-
ulations did not significantly interfere with our data. In
our cross-sectional study, part of the age-related differ-
ences could in theory be due to changes in the environ-
ment in the last century, such as improvement in health
care and nutrition, but this would also apply to the
master athletes. The deterioration in ventilatory function
in the control population is well established. Therefore,
we contend that the age-related differences we observed
in master athletes similarly reflect a pattern of intra-
individual changes with age in ventilatory function in
athletes. The few longitudinal data that are available
appear to support our conclusions.
Conclusions
In conclusion, ventilatory function in master athletes
was superior to that in age-matched controls in this
study. The absence of any group difference in maximal
ventilatory pressure generation suggests that non-
muscular, and thus non-trainable factors are responsi-
ble for the better ventilatory function in the athletes.
The better ventilatory function is most likely a reflec-
tion of self-selection and attrition bias in the master
athletes. The results also support the notion in the
literature that a decrease in ventilatory function may
become a more important limiting factor of aerobic
capacity with increasing age. However, longitudinal
studies in master athletes and training studies are re-
quired to further elucidate this important aspect.
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